结论CA125不只是卵巢癌的指标，也是一种广谱肿瘤标志物，并且肝硬化等良性疾病也有较高的阳性率，可作为健康体检中筛选异常人群的指标。
Conclusion: CA125 is not only a marker for ovarian cancer, but a broad-spectrum tumor marker. There are higher positive rates of CA125 in some benign diseases including hepatocirrhosis.
检测alcam的表达可作为预测卵巢恶性上皮性肿瘤发生的一项指标。
Detection ALCAM expression can be used as an index of predicting ovarian malignant epithelial neoplasm occurrence.
结论？肿瘤组织的血管生成在卵巢癌的浸润性生长及转移方面起着重要作用，MVD可作为判断恶性卵巢肿瘤预后的一项重要指标。
Conclusions? Tumor angiogenesis plays an important role in tumor invasion and metastasis. MVD may serve as a significant prognostic indicator in EOC.
结论：血浆DNA水平有可能成为辅助早期诊断卵巢恶性肿瘤、判断肿瘤侵袭转移情况和预测预后的指标之一。
Conclusion The plasma DNA level may have a potential use in early diagnosis and serve as a predict marker for metastasis potential and prognosis of ovarian cancer.
卵巢癌是妇科恶性肿瘤中致死率最高的肿瘤，目前通常用于判断卵巢癌预后的指标有FIGO分期、肿瘤分级、肿瘤组织学类型等。
Ovarian carcinoma is the most lethal gynecologic malignancy. Nowadays, conventional prognostic markers in ovarian cancer have included FIGO stage, tumor grade, histology et al.
卵巢癌是妇科恶性肿瘤中致死率最高的肿瘤，目前通常用于判断卵巢癌预后的指标有FIGO分期、肿瘤分级、肿瘤组织学类型等。
Ovarian carcinoma is the most lethal gynecologic malignancy. Nowadays, conventional prognostic markers in ovarian cancer have included FIGO stage, tumor grade, histology et al.
应用推荐